ABAyca Bilginoglu

Ayca Bilginoglu

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article


Ayca Bilginoglu has a total of 40 co-authors. Here are the top co-authors by number of shared publications:


Latest Publications

  • Open Access

    Ion Homeostasis Disturbances and Their Cellular Consequences in Metabolic Syndrome

    by Ayca Bilginoglu Topcu

    Metabolic syndrome (MetS) is increasingly understood as a network disorder in which disturbances across multiple cellular systems converge to promote metabolic and cardiovascular dysfunction. Although ion homeostasis is essential for cellular function, researchers have often considered its contribution to MetS separately for individual ions or within specific disease contexts. In this narrative review, we propose an integrated framework in which disturbances in calcium (Ca2+), magnesium (Mg2+), sodium (Na+), potassium (K+), zinc (Zn2+), and iron (Fe) homeostasis are viewed as interconnected components of metabolic dysfunction rather than isolated abnormalities. We examine how altered ion gradients, transport processes, buffering mechanisms, and intracellular compartmentalization interact with mitochondrial and endoplasmic reticulum function, redox balance, inflammatory signaling, and metabolic pathways. Particular attention is given to the crosstalk between ion-dependent processes and insulin–AMP-activated protein kinase (AMPK)–mechanistic target of rapamycin (mTOR) signaling, as well as to their links with mitochondrial dysfunction, oxidative stress, endoplasmic reticulum (ER) stress, and regulated cell death pathways. We further distinguish interactions between ionic systems that have been directly demonstrated from links inferred only through shared downstream effectors, specify the level at which ion status was assessed, and separate ionic effects on insulin secretion from those on insulin action. Rather than providing a descriptive catalog of ion abnormalities, this review synthesizes the available evidence into a systems-level model of ion–metabolism interactions in MetS and identifies major unresolved mechanistic questions. This framework highlights the interconnected ion–metabolism network as a relevant feature of metabolic dysregulation in MetS and provides a basis for future studies integrating ionomics with metabolic, molecular, and spatially resolved approaches.

  • Metabolic Syndrome Effects over Heart Tissue: A Histomorphological Glance under the Light of p97/VCP and SVIP

    by Şeyma Kipel, Ayça Bilginoğlu Topcu, Makbule Fulya Tutar Selçuk, Hilal Nakkaş

    Metabolic syndrome(MetS) is a cluster of metabolic disorders that significantly increases the risk of heart disease and type 2 diabetes. p97/VCP (Valosin-Containing Protein), is an ATPase enzyme that regulates many vital processes in the cell such as cell cycle control, apoptosis, protein degradation, and cellular stress. Small VCP-interacting protein (SVIP) has various important functions in the cell which are particularly in the endoplasmic reticulum and proteasome systems. SVIP is a small but effective regulator of the protein recycling and quality control system in the cell. It affects processes such as cellular stress response, protein accumulation, and degradation, particularly through its interaction with the p97/VCP protein. MetS is one of the most important risk factors for cardiovascular diseases. However, the roles of p97/VCP and SVIP in cardiac tissue affected by MetS remain unclear. Therefore, this study aimed to investigate the histomorphological changes and the expression levels of p97/VCP and SVIP in rat heart tissue in a MetS model. The histomorphological alterations in heart tissues were evaluated using Hematoxylin-Eosin and Weigert Van Gieson staining methods. Using the immunohistochemical technique, the expression of p97/VCP and SVIP in rat heart tissue were examined. Statistical analyses were conducted and p

  • Open Access

    The Role of Oxidative Stress in the Effect of Quercetin on Na+/K+-ATPase Expression in Skeletal Muscle in a Metabolic Syndrome Model

    by Ayca Bilginoglu Topcu

    Metabolic syndrome (MeS) is a multifactorial disorder characterized by insulin resistance, dyslipidemia, hypertension, and obesity, and oxidative stress plays a key role in tissue damage in this syndrome. This study aimed to investigate this role in Na+/K+-ATPase (NKA) expression in skeletal muscle and to evaluate the effects of quercetin. A high-sucrose-diet-induced MeS model was established in Wistar albino rats (n = 32), and skeletal muscle tissues were analyzed. Biochemical parameters were measured, including aspartate aminotransferase (AST), lactate dehydrogenase (LDH), total antioxidant status (TAS), total oxidant status (TOS), superoxide dismutase (SOD), and malondialdehyde (MDA). In addition, thioredoxin-1 (TRX1) and NKA protein expression levels were evaluated using Western blot analysis. In the MeS group, AST, TAS, TRX1, and NKA expression significantly decreased, while LDH, TOS, SOD, and MDA levels increased, indicating disrupted redox balance, elevated oxidative stress, and impaired antioxidant defense. Increased MDA and TOS levels reflected enhanced lipid peroxidation, whereas decreased TAS and TRX1 suggested reduced antioxidant capacity. Elevated SOD activity may indicate a compensatory response to excessive reactive oxygen species (ROS). The reduction in NKA expression may contribute to impaired ion transport and potential skeletal muscle dysfunction. Quercetin administration improved oxidative stress markers and partially restored NKA expression. These findings suggest that oxidative stress contributes to NKA dysfunction in MeS, and quercetin may have therapeutic potential by modulating oxidative stress and preserving enzyme function.

  • Open Access

    Impact of Metabolic Syndrome on SVIP and p97/VCP Expression in Renal Tissue

    by Şeyma Kipel, Hilal Nakkaş, Ayça Bilginoğlu Topcu

    Objective: Metabolic syndrome (MetS) is a clinical condition in which a series of metabolic disorders occur together, increasing the risk of cardiovascular diseases and type 2 diabetes. p97/VCP is a member of the AAA+ ATPase protein family, which functions in various intracellular mechanisms. It plays a critical role, particularly in maintaining proteostasis and ERAD. SVIP is an adaptor protein found on the endoplasmic reticulum membrane. It can bind to p97/VCP and suppress its role in processes such as ERAD. MetS affects renal tissue through multifaceted mechanisms, increasing the risk of developing chronic kidney disease. This situation plays a key role in the development of diabetic nephropathy and hypertensive nephropathy in particular. Very little is known about the role of p97/VCP and SVIP in the MetS kidney. So, it is important to study p97/ VCP and SVIP in MetS kidney tissue.Material and Methods: Hematoxylin Eosin and Azan Trichrome stainings were used to examine the histomorphology of rat kidney tissue. The expression of p97/VCP and SVIP in tissue was investigated using immunohistochemistry.Results: Both the control and MetS kidney tissue showed signs of p97/VCP and SVIP expression. Comparing the two experimental groups, the MetS group showed higher SVIP expression and lower p97/VCP expression than the control group.Conclusion: Demonstrating the morphological alterations of the kidney in the control and MetS groups is crucial and histologically significant. Furthermore, SVIP and p97/VCP expressions in metabolic syndrome are significant for chronic renal disease. These results represent a significant advancement in our knowledge of the causes and consequences of metabolic syndrome.

  • Open Access

    Quercetin Administration Mitigated Oxidative Stress And The Alterations In Thioredoxin-1 Levels Caused By High Sucrose Intake In Rat Thoracic Aortas.

    by Ayça Bilginoğlu Topcu

    Oxidative stress is considered a contributing factor to the rapid advancement of complications associated with metabolic syndrome. Additionally, thioredoxins are essential components required for the redox regulation of protein thiol groups. The objective of this study was to examine the roles of quercetin and thioredoxin-1 in the mechanisms that may mediate their therapeutic potential. Male Wistar rats were administered 32% sucrose in their drinking water over a 20-week period to induce metabolic syndrome. Following this induction, quercetin was given orally at a dose of 15 mg/kg/day. At the conclusion of the study, blood samples from each group were evaluated for lipid profiles and thioredoxin-1 protein levels. In addition, antioxidant enzyme activities, total oxidant and antioxidant status, nitric oxide metabolite concentrations, protein thiol levels, and thioredoxin-1 protein levels were assessed in aortic tissues. Rats exposed to high sucrose intake exhibited elevated serum lipid concentrations, malondialdehyde levels, total oxidant status, and thioredoxin-1 protein levels in the serum. These increases were significantly mitigated by quercetin treatment. Furthermore, sucrose consumption resulted in a notable reduction in antioxidant markers, including superoxide dismutase, glutathione peroxidase, catalase, total antioxidant status, and thioredoxin-1, within aortic tissue homogenates. Supplementation with quercetin effectively reversed these declines, restoring antioxidant parameters. Overall, the findings indicate that quercetin plays a protective role under oxidative stress by strengthening the body's antioxidant defense mechanisms, particularly through its regulatory effect on thioredoxin-1, a key antioxidant protein involved in maintaining cellular redox balance.


  • Pioglitazone provides beneficial effect in metabolic syndrome rats via affecting intracellular Na+ Dyshomeostasis

    by Ayca Bilginoglu, Makbule Fulya Tutar Selcuk, Hilal Nakkas, Belma Turan

    Metabolic syndrome, is associated impaired blood glucose level, insulin resistance, and dyslipidemia caused by abdominal obesity. Also, it is related with cardiovascular risk accumulation and cardiomyopathy. The hypothesis of this study was to examine the effect of thiazolidinediones such as pioglitazone on intracellular Na+ homeostasis in heart of metabolic syndrome male rats. Abdominal obesity and glucose intolerance had measured as a marker of metabolic syndrome. Intracellular Na+ concentration ([Na+]i) at rest and [Na+]i during pacing with electrical field stimulation were determined in freshly isolated cardiomyocytes. Also, TTX-sensitive Na+- channel current (INa) density and I-V characteristics of these channels were measured to understand [Na+]i homeostasis. We determined the protein levels of Na+/Ca2+ exchanger and Na+-K+ pump to understand the relation between [Na+]i homeostasis. High sucrose intake significantly increased body mass and blood glucose level of the rats in the metabolic syndrome group as compared with control group. There was a decrease in INa density and there were differences in points on activation curve of INa. Basal [Na+]i in metabolic syndrome group significantly increased but there was a significantly decrease in [Na+]i in stimulated cardiomyocytes in metabolic syndrome. Furthermore, pioglitazone induced decreases in the basal [Na+]i and preserved the decrease in INa and [Na+]i in stimulated cardiomyocytes to those of controls. Histologically, metabolic syndrome affected heart and associated tissues together with many other organs. Results of the present study suggest that pioglitazone has significant beneficial effects on metabolic syndrome associated disturbances in the heart via effecting Na+ homeostasis in cardiomyocytes.


  • Protective effect of melatonin on adriamycin-induced cardiotoxicity in rats

    by Ayca Bilginoglu

    Adriamycin is one of the most widely used anticancer drugs. The major limiting factor of using this drug is the development of cardiotoxicity. However, melatonin (N-acetyl-5-methoxytryptamine) is a ubiquitous molecule as a good antioxidant that may protect the heart. We investigated whether or not pretreatment with melatonin can attenuate adriamycin-induced cardiotoxicity. All procedures and experiments were approved by the Animal Ethics Committee of Gazi Osman Paşa University (2012-HADYEK-022). Adult male Wistar-Albino rats were randomly divided into four groups, namely control (CON, n=7), melatonin (MEL, n=7), adriamycin (ADR, n=7), and adriamycin+melatonin (ADR+MEL, n=7) groups. Cardiotoxicity in rats was induced by adriamycin injection (cumulative dose: 18 mg/kg, intraperitoneal [i.p.]) at an interval of 24 hours (h) on the 5th, 6th and 7th days. Rats receiving melatonin treatment in the adriamycin group received melatonin (10 mg/kg/day, i.p.) for 7 days and were injected with adriamycin (18 mg/kg, i.p.) on 5th, 6th and 7th days. On the 8th day, gravimetric, electrocardiography (ECG) and biochemical parameters were assessed. Adriamycin induction caused changes in the ECG pattern, including ST-segment elevation and decreased R-amplitude, increase in the serum levels of cardiac injury markers (creatine kinase [CK], CK-MB, aspartate transaminase, and lactate dehydrogenase), decrease in the antioxidant enzymes activity (superoxide dismutase, glutathione peroxidase), elevated lipid peroxidation (malondialdehyde), and altered lipid profile in the serum. Melatonin treatment prevented all the parameters of adriamycin-induced cardiotoxicity in rats. Melatonin has a protective effect on the heart against adriamycin-induced cardiotoxicity in rats.


  • Intracellular Levels of Na+ and TTX-sensitive Na+ Channel Current in Diabetic Rat Ventricular Cardiomyocytes

    by Ayca Bilginoglu, Hilmi Burak Kandilci, Belma Turan

    Intracellular Na+ ([Na+] i ) is an important modulator of excitation–contraction coupling via regulating Ca2+ efflux/influx, and no investigation has been so far performed in diabetic rat heart. Here, we examined whether any change of [Na+] i in paced cardiomyocytes could contribute to functional alterations during diabetes. Slowing down in depolarization phase of the action potential, small but significant decrease in its amplitude with a slight depolarized resting membrane potential was traced in live cardiomyocytes from diabetic rat, being parallel with a decreased TTX-sensitive Na+ channel current (I Na) density. We recorded either [Na+] i or [Ca2+] i by using a fluorescent Na+ indicator (SBFI-AM or Na-Green) or a Ca2+ indicator (Fura 2-AM) in freshly isolated cardiomyocytes. We examined both [Na+] i and [Ca2+] i at rest, and also [Na+] i during pacing with electrical field stimulation in a range of 0.2–2.0 Hz stimulation frequency. In order to test the possible contribution of Na+/H+ exchanger (NHE) to [Na+] i , we examined the free cytoplasmic [H+] i changes from time course of [H+] i recovery in cardiomyocytes loaded with SNARF1-AM by using ammonium prepulse method. Our data showed that [Na+] i in resting cells from either diabetic or control group was not significantly different, whereas the increase in [Na+] i was significantly smaller in paced diabetic cardiomyocytes compared to that of the controls. However, resting [Ca2+] i in diabetic cardiomyocytes was significantly higher than that of the controls. Here, a lower basal pH i in diabetics compared with the controls correlates also with a slightly higher but not significantly different NHE activity and consequently a similar Na+ loading rate at resting state with a leftward shift in pH sensitivity of NHE-dependent H+-flux. NHE protein level remained unchanged, while protein levels of Na+/K+ ATPase and Na+/Ca2+ exchanger were decreased in the diabetic cardiomyocytes. Taken together, the present data indicate that depressed I Na plays an important role in altered electrical activity with less Na+ influx during contraction, and an increased [Ca2+] i load in these cells seems to be independent of [Na+] i . The data with insulin treatment suggest further a recent balance between Na+ influx and efflux proteins associated with the [Na+] i , particularly during diabetes.


  • Profound cardioprotection with timolol in a female rat model of aging-related altered left ventricular function

    by Nazli N. Sozmen, Erkan Tuncay, Ayca Bilginoglu, Belma Turan

    Increasing evidence shows a marked beneficial effect with β-blockers in heart dysfunction via scavenging reactive oxygen species. Previously we showed that chronic treatment with either timolol or propranolol possessed similar beneficial effects for heart function in male rats as age increased, whereas only timolol exerted similar benefits in female rats. Therefore, in this study, we aimed first to examine the cellular bases for age-related alterations in excitation–contraction coupling in ventricular myocytes from female rats and, second, to investigate the hypothesis that age-related changes in [Ca2+]ihomeostasis and receptor-mediated system can be prevented with chronic timolol treatment. Chronic timolol treatment of 3-month-old female rats abolished age-related decrease in left ventricular developed pressure and the attenuated responses to β-adrenoreceptor stimulation. It also normalized the altered parameters of [Ca2+]itransients, decreased Ca2+loading of sarcoplasmic reticulum and increased basal [Ca2+]i, and decreased L-type Ca2+currents in 12-month-old female rats compared with the 3-month-old group. Adenylyl cyclase activity, β-adrenoreceptor affinity to its agonist, and β-adrenoreceptor density of the 12-month-old group are normalized to those of the 3-month-old group. Moreover, timolol treatment prevented dysfunction of the antioxidant system, including increased lipid peroxidation, decreased ratio of reduced glutathione to oxidized glutathione, and decreased activities of thioredoxin reductase and glucose-6-phosphate dehydrogenase, in the left ventricle of hearts from the 12-month-old group. Our data confirmed that aging-related early myocardial impairment is primarily related to a dysfunctional antioxidant system and impairment of Ca2+homeostasis, which can be prevented with chronic timolol treatment.


  • Treatments with sodium selenate or doxycycline offset diabetes-induced perturbations of thioredoxin-1 levels and antioxidant capacity

    by Mustafa Atalay, Ayca Bilginoglu, Tarja Kokkola, Niku Oksala, Belma Turan

    Diabetes is associated with increased oxidative stress and impaired antioxidant defenses. Thioredoxin-1 (TRX-1) is a cytosolic thiol antioxidant and redox-active protein which plays a vital role in the maintenance of reduced intracellular redox state. In this study, the authors examined whether 4-week treatments with sodium selenate and doxycycline—a metalloproteinase-2 inhibitor which also has antioxidant-like effects—offset perturbations in oxidative stress and antioxidant protection in rat liver and skeletal muscle in streptozotocin-induced diabetes (SID) model. Experimental diabetes decreased TRX-1 levels in skeletal muscle and liver. On the other hand, SID increased oxidative stress marker protein carbonyl levels and decreased oxygen radical absorbance capacity (ORAC), an indicator of antioxidant capacity, in liver. A 4-week treatment of sodium selenate to diabetic rats decreased blood glucose levels moderately, while doxycycline treatment caused a reduction in weight loss of diabetic rats. Both doxycycline and sodium selenate prevented diabetes-induced decrease of TRX-1 levels in skeletal muscle, whereas only doxyxycline was effectively preventing diabetes-induced decrease of TRX-1 in liver. Furthermore, both treatments prevented diabetes-induced altered levels of protein carbonyls and ORAC in liver, and restored free and total protein thiol levels in both skeletal muscle and liver. In conclusion, the data of this study provides further evidence that sodium selenate and doxycycline treatments may control oxidative stress and improve antioxidant defense in diabetes.